文献速递创伤与烧伤心脑血管急症

院前氨甲环酸给药时机对创伤性脑损伤结局的影响:一项随机对照试验的亚组分析

The effects of timing of prehospital tranexamic acid on outcomes after traumatic brain injury: Subanalysis of a randomized controlled trial.
PubMed 文献 · J Trauma Acute Care Surg · 2022-09-23
一句话结论中重度TBI患者在伤后2小时内接受院前TXA时,伤后45分钟内给药未观察到死亡率获益,但深静脉血栓和脑血管痉挛发生率更低;结果支持推荐疑似TBI患者在伤后45分钟内给予TXA的方案。

该研究为多机构、双盲随机对照试验的亚组分析,纳入649例疑似TBI且GCS≤12、SBP≥90的钝性或穿透性损伤患者,均在伤后2小时内接受院前TXA(2g负荷或1g负荷+1g 8小时输注)。比较伤后<45分钟给药(早期组354例)与≥45分钟给药(晚期组259例),发现28天和6个月死亡率、6个月GOSE和残疾评定量表评分均无差异;晚期给药与更高的深静脉血栓发生率(0.8% vs 3.4%,p=0.02)和脑血管痉挛发生率(0% vs 2%,p=0.01)相关,并与院前转运时间延长和需要院前气道管理相关(p<0.01)。结论支持推荐疑似TBI患者在伤后45分钟内给予TXA的方案。

要点

  • 在伤后2小时内接受院前TXA的中重度TBI患者中,伤后45分钟内给药与≥45分钟给药相比,28天和6个月死亡率无差异。
  • 晚期给药(≥45分钟)与更高的深静脉血栓发生率相关(0.8% vs 3.4%,p=0.02)。
  • 晚期给药(≥45分钟)与更高的脑血管痉挛发生率相关(0% vs 2%,p=0.01)。
  • 晚期给药还与院前转运时间延长和需要院前气道管理相关(p<0.01)。
  • 作者结论支持推荐疑似TBI患者在伤后45分钟内给予TXA的方案。

适用人群与场景

  • 多机构、双盲随机对照试验中纳入的钝性或穿透性损伤且疑似TBI的患者,Glasgow昏迷评分≤12、收缩压≥90,并在伤后2小时内接受院前TXA(2g负荷或1g负荷+1g 8小时输注)。

诊断标准与关键阈值

  • 疑似TBI:Glasgow昏迷评分≤12,收缩压≥90。
  • 早期给药定义为伤后<45分钟,晚期给药定义为伤后≥45分钟。

处置流程与药物剂量

  • 院前给予TXA:2g负荷或1g负荷+1g 8小时输注,均在伤后2小时内开始。
  • 作者结论支持推荐疑似TBI患者在伤后45分钟内给予TXA的方案。

红旗征与不能漏的情况

  • 晚期给药(≥45分钟)与深静脉血栓发生率升高相关(0.8% vs 3.4%,p=0.02)。
  • 晚期给药(≥45分钟)与脑血管痉挛发生率升高相关(0% vs 2%,p=0.01)。

研究设计与关键结果

  • 研究类型:多机构、双盲随机对照试验的亚组分析;样本量649例(早期组354例,晚期组259例)。
  • 主要终点:28天和6个月死亡率、6个月Glasgow结局量表扩展版和残疾评定量表评分在早期与晚期给药组间无差异。
  • 次要终点:晚期给药组深静脉血栓发生率3.4% vs 早期组0.8%(p=0.02);晚期给药组脑血管痉挛发生率2% vs 早期组0%(p=0.01);晚期给药与院前转运时间延长和需要院前气道管理相关(p<0.01)。

证据类型、等级与局限

  • 证据类型:多机构、双盲随机对照试验的亚组分析;证据等级:治疗/管理,Level II。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论支持推荐疑似TBI患者在伤后45分钟内给予TXA的方案。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Tranexamic acid (TXA) is an antifibrinolytic that has shown some promise in improving outcomes in traumatic brain injury (TBI), but only when given early after injury. We examined the association between timing of prehospital TXA administration and outcomes in patients with moderate to severe TBI.

METHODS: Patients enrolled in the multi-institutional, double-blind randomized prehospital TXA for TBI trial with blunt or penetrating injury and suspected TBI (Glasgow Coma Scale score ≤ 12, SBP ≥90) who received either a 2-g TXA bolus or a 1-g bolus plus 1 g 8 hour infusion within 2 hours of injury were analyzed. Outcomes were compared between early administration (<45 minutes from injury) and late administration ≥45 minutes from injury) using a χ 2 , Fischer's exact test, t test, or Mann-Whitney U test as indicated. Logistic regression examined time to drug as an independent variable. A p value less than 0.05 was considered significant.

RESULTS: Six hundred forty-nine patients met inclusion criteria (354 early and 259 late). Twenty-eight-day and 6-month mortalities, 6-month Glasgow Outcome Scale-Extended, and disability rating scale scores were not different between early and late administration. Late administration was associated with higher rates of deep venous thrombosis (0.8 vs. 3.4%, p = 0.02), cerebral vasospasm (0% vs. 2%, p = 0.01), as well as prolonged EMS transport and need for a prehospital airway ( p < 0.01).

CONCLUSION: In patients with moderate or severe TBI who received TXA within 2 hours of injury, no mortality benefit was observed in those who received treatment within 45 minutes of injury, although lower rates of select complications were seen. These results support protocols that recommend TXA administration within 45 minutes of injury for patients with suspected TBI.

LEVEL OF EVIDENCE: Therapeutic/Care Management; Level II.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Brito AMP, Schreiber MA, El Haddi J, et al. The effects of timing of prehospital tranexamic acid on outcomes after traumatic brain injury: Subanalysis of a randomized controlled trial. J Trauma Acute Care Surg. 2022. PMID: 36138535. doi:10.1097/TA.0000000000003767

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。